A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

被引:612
作者
Wynn, RF
Hart, CA
Corradi-Perini, C
O'Neill, L
Evans, CA
Wraith, JE
Fairbairn, LJ
Bellantuono, I
机构
[1] Royal Manchester Childrens Hosp, Stem Cell Res Grp, Manchester, Lancs, England
[2] Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester, Lancs, England
[3] Canc Res UK Gene Therapy Grp, Paterson Inst Canc Res, Manchester, Lancs, England
[4] UMIST, Dept Biomol Sci, Leukemia Res Fund, Manchester, Lancs, England
关键词
D O I
10.1182/blood-2004-02-0526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Homing of bone marrow stromal cells (MSCs) to bone and bone marrow after transplantation, important for the correction of conditions such as metabolic storage disorders, can occur but with poor efficiency. Substantial improvements in engraftment will be required in order to derive a clinical benefit from MSC transplantation. Chemokines are the most important factors controlling cellular migration. Stromal-derived factor-1 (SDF-1) has been shown to be critical in promoting the migration of cells to the bone marrow, via its specific receptor CXCR4. The aim of our study was to investigate CXCR4 expression on MSCs and its role in mediating migration to bone marrow. We show that CXCR4, although present at the surface of a small subset of MSCs, is important for mediating specific migration of these cells to bone marrow. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2643 / 2645
页数:3
相关论文
共 20 条
  • [1] Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I
    Baxter, MA
    Wynn, RF
    Deakin, JA
    Bellantuono, I
    Edington, KG
    Cooper, A
    Besley, GTN
    Church, HJ
    Wraith, JE
    Carr, TF
    Fairbairn, LJ
    [J]. BLOOD, 2002, 99 (05) : 1857 - 1859
  • [2] Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
  • [3] 2-F
  • [4] Post-translational and cell type-specific regulation of CXCR4 expression by cytokines
    Brühl, H
    Cohen, CD
    Linder, S
    Kretzler, M
    Schlöndoff, D
    Mack, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (11) : 3028 - 3037
  • [5] CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO
    DEXTER, TM
    ALLEN, TD
    LAJTHA, LG
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) : 335 - 344
  • [6] Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO
  • [7] 2-7
  • [8] Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
    Horwitz, EM
    Gordon, PL
    Koo, WKK
    Marx, JC
    Neel, MD
    McNall, RY
    Muul, L
    Hofmann, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) : 8932 - 8937
  • [9] Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy
    Koç, ON
    Gerson, SL
    Cooper, BW
    Dyhouse, SM
    Haynesworth, SE
    Caplan, AI
    Lazarus, HM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 307 - 316
  • [10] Human CD34+CXCR4- sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation
    Kollet, O
    Petit, I
    Kahn, J
    Samira, S
    Dar, A
    Peled, A
    Deutsch, V
    Gunetti, M
    Piacibello, W
    Nagler, A
    Lapidot, T
    [J]. BLOOD, 2002, 100 (08) : 2778 - 2786